Ono Pharmaceutical Co., Ltd. OPHLY
Set alert
4.85 USD +0.19 +4.08%
As of Nov 2, 3:46 PM ET
4.85 Day range 4.85
3.97 52-week range 5.75
- YTD
- +6.59%
- 1 year
- +21.55%
- Open
- 4.85
- Prev close
- 4.66
- Mkt cap
- 6.84B
- Vol
- 100
- Avg vol
- 51.06K
- EPS
- 0.35
- P/E
- 13.86
More statistics
- Low
- 4.85
- High
- 4.85
- Earnings
- Nov 2, 2026
3M chart
Events in this range
- Sep 29, 2026Dividend: 0.059701
- Nov 2, 2026Earnings: —; estimate 0.08198; surprise —%
Signals (23)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
Newest 20 of 23.
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.08198.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.08198 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | 0.07164 | 0.1076 | +0.04 | +50.20% |
| May 7, 2026 | Mar 31, 2026 | 0.0172 | 0.0037 | -0.01 | -78.49% |
| Feb 1, 2026 | Dec 31, 2025 | 0.09634 | 0.1315 | +0.04 | +36.50% |
| Oct 28, 2025 | Sep 30, 2025 | 0.08968 | 0.1079 | +0.02 | +20.32% |
| Jul 28, 2025 | Jun 30, 2025 | 0.1134 | 0.0865 | -0.03 | -23.72% |
News
- Ono Pharma Announces Results From Five Phase 2 Clinical Studies of ONO-1110, an Endocannabinoid Modulator
- Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
- Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting
- Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
- Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
- Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P.
- Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Call Transcript
- Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript
- Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
- ONO to buy Deciphera Pharmaceuticals at a huge premium
Your note
Sign in to keep a note on OPHLY — it syncs with the Stock Master app.